File(s) not publicly available
Evaluation of levamisole as a treatment for amoebic gill disease of Atlantic salmon, Salmo salar L
journal contribution
posted on 2023-05-16, 12:08 authored by Findlay, VL, Zilberg, D, Munday, BLLevamisole, a known T-cell stimulator and immunomodulator in mammals, has been demonstrated to enhance resistance to amoebic gill disease in Atlantic salmon, Salmo salar L. When used in fresh water baths, dose rates of 1.25, 2.5 and 5 ppm levamisole stimulated resistance to reinfection with Paramoeba sp. that was evident from 2-3 weeks post-treatment. It is proposed that this response is related to enhancement of the non-specific immune system.
History
Publication title
Journal of Fish DiseasesVolume
23Pagination
193-198ISSN
0140-7775Department/School
Institute for Marine and Antarctic StudiesPublisher
Blackwell Science LtdPlace of publication
Oxford, EnglandRepository Status
- Restricted